by University of Nottingham Credit: Pixabay/CC0 Public Domain Two cheap and common drugs could be re-purposed as the first specific treatment for people who experience a type of stroke linked to nearly half of all dementias, according to the results of new research. A clinical trial run by the University of Nottingham and University of Edinburgh...
The U.S. Food and Drug Administration has approved Xenpozyme (olipudase alfa) for pediatric and adult patients with acid sphingomyelinase deficiency (ASMD), a rare genetic disease. ASMD is caused by the lack of an enzyme needed to break down the complex lipid sphingomyelin, which can accumulate in the liver, spleen, lung, and brain. Xenpozyme infusions provide enzyme...
Megan Brooks September 02, 2022 The US Food and Drug Administration (FDA) has approved the biologic agent spesolimab (Spevigo) for the treatment of flares in adults with generalized pustular psoriasis (GPP), the company has announced. “GPP flares can greatly impact a patient’s life and lead to serious, life-threatening complications,” Mark Lebwohl, MD, principal investigator in the pivotal...
